Influence of prostaglandin E1* * Prostandin® - Prostagladin E1 - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report

Soji Okada; Yositugu Masaki; Hirofumi Makino; Kimiaki Sato; Toru Higuchi; Makoto Hiramatu; Zensuke Ota; Yooichiro Miyai; Yasuhisa Ogino; Kayo Takahasi

Influence of prostaglandin E₁^* * Prostandin^® - Prostagladin E₁ - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report

Soji Okada, Yositugu Masaki, Hirofumi Makino, Kimiaki Sato, Toru Higuchi, Makoto Hiramatu, Zensuke Ota, Yooichiro Miyai, Yasuhisa Ogino, Kayo Takahasi

Research output: Contribution to journal › Article › peer-review

Abstract

A case of a 57-year-old man who was admitted to hospital for the treatment of noninsulin dependent diabetes mellitus (NIDDM) and nephrosis is presented. Details of a full clinical and biochemical investigation are given. The patient was put on a diet of 1600 kcal per day and given Lente insulin to restore his fasting blood glucose to normal. Prostoglandin E₁ was then given, 40 μg b.d. intravenously morning and evening to improve his creatintne clearance and reduce urinary protein successfully. Improvement in the nephrosis of diabetic retinopathy was ultimately attained in this one patient. He was discharged from hospital, has remained well for the past year, and able to do light work.

Original language	English
Pages (from-to)	263-266
Number of pages	4
Journal	Clinical Trials Journal
Volume	22
Issue number	3
Publication status	Published - Dec 1 1985

Keywords

Lente insulin
NIDDM
diet
nephrosis
prostaglandin E

ASJC Scopus subject areas

Pharmacology (medical)

Fingerprint Dive into the research topics of 'Influence of prostaglandin E1 Prostandin® - Prostagladin E1 - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report'. Together they form a unique fingerprint.

Cite this

Influence of prostaglandin E₁^* * Prostandin^® - Prostagladin E₁ - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report. / Okada, Soji; Masaki, Yositugu; Makino, Hirofumi; Sato, Kimiaki; Higuchi, Toru; Hiramatu, Makoto; Ota, Zensuke; Miyai, Yooichiro; Ogino, Yasuhisa; Takahasi, Kayo.

In: Clinical Trials Journal, Vol. 22, No. 3, 01.12.1985, p. 263-266.

Research output: Contribution to journal › Article › peer-review

Okada, Soji ; Masaki, Yositugu ; Makino, Hirofumi ; Sato, Kimiaki ; Higuchi, Toru ; Hiramatu, Makoto ; Ota, Zensuke ; Miyai, Yooichiro ; Ogino, Yasuhisa ; Takahasi, Kayo. / Influence of prostaglandin E₁^* * Prostandin^® - Prostagladin E₁ - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report. In: Clinical Trials Journal. 1985 ; Vol. 22, No. 3. pp. 263-266.

@article{129b5aadac424b749c16547802371890,

title = "Influence of prostaglandin E1* * Prostandin{\textregistered} - Prostagladin E1 - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report",

abstract = "A case of a 57-year-old man who was admitted to hospital for the treatment of noninsulin dependent diabetes mellitus (NIDDM) and nephrosis is presented. Details of a full clinical and biochemical investigation are given. The patient was put on a diet of 1600 kcal per day and given Lente insulin to restore his fasting blood glucose to normal. Prostoglandin E1 was then given, 40 μg b.d. intravenously morning and evening to improve his creatintne clearance and reduce urinary protein successfully. Improvement in the nephrosis of diabetic retinopathy was ultimately attained in this one patient. He was discharged from hospital, has remained well for the past year, and able to do light work.",

keywords = "Lente insulin, NIDDM, diet, nephrosis, prostaglandin E",

author = "Soji Okada and Yositugu Masaki and Hirofumi Makino and Kimiaki Sato and Toru Higuchi and Makoto Hiramatu and Zensuke Ota and Yooichiro Miyai and Yasuhisa Ogino and Kayo Takahasi",

year = "1985",

month = dec,

day = "1",

language = "English",

volume = "22",

pages = "263--266",

journal = "Clinical Trials Journal",

issn = "0009-9325",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Influence of prostaglandin E1* * Prostandin® - Prostagladin E1 - Ono Pharmaceutical Co. Ltd., Osaka, Japan. on proteinuria of diabetic nephropathy. A case report

AU - Okada, Soji

AU - Masaki, Yositugu

AU - Makino, Hirofumi

AU - Sato, Kimiaki

AU - Higuchi, Toru

AU - Hiramatu, Makoto

AU - Ota, Zensuke

AU - Miyai, Yooichiro

AU - Ogino, Yasuhisa

AU - Takahasi, Kayo

PY - 1985/12/1

Y1 - 1985/12/1

N2 - A case of a 57-year-old man who was admitted to hospital for the treatment of noninsulin dependent diabetes mellitus (NIDDM) and nephrosis is presented. Details of a full clinical and biochemical investigation are given. The patient was put on a diet of 1600 kcal per day and given Lente insulin to restore his fasting blood glucose to normal. Prostoglandin E1 was then given, 40 μg b.d. intravenously morning and evening to improve his creatintne clearance and reduce urinary protein successfully. Improvement in the nephrosis of diabetic retinopathy was ultimately attained in this one patient. He was discharged from hospital, has remained well for the past year, and able to do light work.

AB - A case of a 57-year-old man who was admitted to hospital for the treatment of noninsulin dependent diabetes mellitus (NIDDM) and nephrosis is presented. Details of a full clinical and biochemical investigation are given. The patient was put on a diet of 1600 kcal per day and given Lente insulin to restore his fasting blood glucose to normal. Prostoglandin E1 was then given, 40 μg b.d. intravenously morning and evening to improve his creatintne clearance and reduce urinary protein successfully. Improvement in the nephrosis of diabetic retinopathy was ultimately attained in this one patient. He was discharged from hospital, has remained well for the past year, and able to do light work.

KW - Lente insulin

KW - NIDDM

KW - diet

KW - nephrosis

KW - prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=46549098226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46549098226&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:46549098226

VL - 22

SP - 263

EP - 266

JO - Clinical Trials Journal

JF - Clinical Trials Journal

SN - 0009-9325

IS - 3

ER -